Prosecution Insights
Last updated: July 17, 2026

Curium US LLC

7 pending office actions • 2 art units • 5 examiners • 0 of 7 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
6
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
6
Medium (86%)
1
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (71%)
§102 only1 (14%)
Double-patenting only1 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DONOHUE, SEAN R 3 41.6% +21.4%
CRAIG, KAILA ANGELIQUE 1 31.7% +27.8%
LEWOCZKO, EVAN MICHAEL 1
MASKELL, MICHAEL P 1 86.1% +9.2%
VU, JAKE MINH 1 40.5% +27.6%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18738493 TARGET CARRIER ASSEMBLY AND IRRADIATION SYSTEM MASKELL, MICHAEL P

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19209267 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF DONOHUE, SEAN R
19208200 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF DONOHUE, SEAN R
19198982 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF DONOHUE, SEAN R
18798723 METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION CRAIG, KAILA ANGELIQUE
18681264 RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY VU, JAKE MINH

Top Art Units

Art UnitApps
1618 5
1612 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19209267 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF DONOHUE, SEAN R 1618 §103 Non-Final OA Pending May 15, 2025
19208200 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF DONOHUE, SEAN R 1618 §103 Non-Final OA Pending May 14, 2025
19198982 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF DONOHUE, SEAN R 1618 §103 Non-Final OA Pending May 05, 2025
18798723 METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION CRAIG, KAILA ANGELIQUE 1618 §103 Final Rejection Pending Aug 08, 2024
18791300 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF LEWOCZKO, EVAN MICHAEL 1612 DP Non-Final OA Pending Jul 31, 2024
18738493 TARGET CARRIER ASSEMBLY AND IRRADIATION SYSTEM MASKELL, MICHAEL P §102 Non-Final OA Pending Jun 10, 2024
18681264 RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY VU, JAKE MINH 1618 §103 Non-Final OA Pending Feb 05, 2024

Managing Curium US LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month